Delivery Order SPE2DB25D3108-SPE2DB25FPDZB
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $5,208.36 to AmerisourceBergen Drug Corp for 30 tablets of DESCOVY 200-25 mg, an antiretroviral medication used in HIV treatment and prevention. The contract, executed on July 24, 2025, with an ultimate completion date of July 25, 2025, represents a firm fixed-price delivery order with no set-aside designation, indicating competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, served as the prime...
- The Defense Logistics Agency awarded a delivery order valued at $30,140.34 to AmerisourceBergen Drug Corp for DESCOVY 200-25 mg tablets (30-count units) on August 20, 2025, with an ultimate completion date of August 21, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. DESCOVY is an antiretroviral medication used for HIV prevention and treatment,...
- The Defense Logistics Agency awarded a $15,784.84 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 30-unit supplies of DESCOVY 200-25 mg tablets, an antiretroviral medication used in HIV treatment and prevention. This non-set-aside competitive award was issued on July 31, 2025, with an ultimate completion date of August 1, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under...
- The Defense Logistics Agency awarded a delivery order valued at $4,775.57 to AmerisourceBergen Drug Corp for the supply of DESCOVY 200-25 mg tablets in quantities of 30, with an ultimate completion date of August 13, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. DESCOVY is a prescription antiretroviral medication used in HIV treatment and...
- The Defense Logistics Agency awarded a delivery order valued at $5,900.78 to AmerisourceBergen Drug Corp for DESCOVY 200-25 mg tablets (30-count units) on August 8, 2025, with a completion date of August 11, 2025. This competitively awarded, non-set-aside firm fixed price delivery order will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. DESCOVY is an antiretroviral medication used in HIV treatment and prevention, reflecting the Department of Defense's...
- The Defense Logistics Agency awarded a delivery order valued at $8,917.36 to AmerisourceBergen Drug Corp for DESCOVY 200-25 mg tablets (30-count units) on July 25, 2025, with an ultimate completion date of July 28, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. DESCOVY is an antiretroviral medication used in HIV treatment and prevention,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $16,002.20 to AmerisourceBergen Drug Corp for 30-unit bottles of DESCOVY 200-25 mg tablets on August 6, 2025, with completion targeted for August 7, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award to the pharmaceutical distributor's Corporate Office location in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for DESCOVY 200-25 mg tablets in quantities of 30 units, valued at $28,822.69. This firm fixed-price delivery order, which is not set-aside, was awarded on July 8, 2025, with an ultimate completion date of July 9, 2025. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. DESCOVY is an HIV prevention and treatment medication, reflecting the company's role as a...
- AmerisourceBergen Drug Corp has been awarded a $26,023.92 delivery order by the Defense Logistics Agency (DLA) for 30-count bottles of DESCOVY 200-25 mg tablets, an antiretroviral medication used in HIV prevention and treatment. Issued on August 5, 2025, with a completion deadline of August 6, 2025, this firm fixed-price contract represents a competitively awarded, non-set-aside procurement with performance at the contractor's Conshohocken, Pennsylvania facility. The delivery order is executed...
- The Defense Logistics Agency awarded a delivery order valued at $15,530.23 to AmerisourceBergen Drug Corp for DESCOVY 200-25 mg tablets (30-count units) on September 16, 2025, with a completion date of September 17, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the awardee's facility in Conshohocken, Pennsylvania. DESCOVY is an antiretroviral medication used for HIV treatment and prevention, reflecting the Defense...
- SPE2DB25D3108Indefinite Delivery Contract
- SPE2DB25D3108-SPE2DB25FPDZBDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 30-count tablets of DESCOVY 200-25 mg, an antiretroviral medication used in HIV treatment and prevention. This non-set-aside, competitively awarded contract carries a ceiling value of $6,981.93 under a firm fixed-price arrangement, with performance to be completed by September 18, 2025. The delivery order was issued on September 17, 2025, and will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a single task under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive pharmaceutical support vehicle extending through December 2026. As a major pharmaceutical distributor and critical federal medical supply vendor, AmerisourceBergen leverages this prime contract vehicle to supply a wide range of brand-name and generic medications, vaccines, and medical supplies to military healthcare systems and other federal customers, including the Defense Health Agency and U.S. Coast Guard. The company's continued selection for such medical procurement underscores its capability to meet federal requirements through open competition and its established role in supporting Department of Defense healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.0k | 9/17/25 |